Aetos Pharma is a Thioridazine Hydrochloride 10mg, 15mg and 50mg Tablets Manufacturer in India and also Exporters in the Latin American region including countries such as Bolivia, Ecuador, Dominican Republic, Chile, Venezuela, Brazil, Colombia, Mexico, Guyana, Guatemala, Panama, Trinidad and Tobago, and El Salvador.
Thioridazine Hydrochloride 10mg, 15mg and 50mg Tablets Manufacturer, Exporter, and Supplier in India
The state of one’s mental health is crucial to overall wellbeing, and pharmaceutical advances have produced ground-breaking treatments for a variety of mental health issues. Thioridazine Tablets, produced by the renowned Aetos Pharma, have become a leader in successfully treating mental health conditions
Pioneering Excellence in Pharmaceutical Innovation:
The pharmaceutical company Aetos Pharma is well-known for providing cutting-edge drugs that improve and lengthen human life. Aetos Pharma has gained international acclaim for its dedication to quality, safety, and efficacy in its products by placing a heavy emphasis on research and development. The medicine is manufactured in our WHO-GMP accredited facility made as per the EU-GMP standards.
Overview of Thioridazine Hydrochloride Tablets by Aetos Pharma
Thioridazine is primarily used to treat a variety of mental health conditions and is a member of the drug class known as antipsychotics. Thioridazine Tablets are designed to provide patients with illnesses like schizophrenia and other psychotic disorders with a trustworthy and efficient therapy choice.
Safety and Efficacy:
To assure their safety and effectiveness, thioridazine tablets have undergone thorough clinical testing. To ensure the highest level of product perfection, Aetos Pharma has put in place strict quality control measures that adhere to worldwide standards and regulatory criteria. Patients can rely on Thioridazine Tablets to properly treat their mental health concerns.
Available in three presentations/strengths of 10 mg, 25 mg, 50mg for optimal flexibility:
Thioridazine Tablets are offered in three strengths: 10 mg, 25 mg, and 50 mg, taking into account the various demands of patients. This variety of alternatives enables medical personnel to customize the dosage to meet specific patient needs, guaranteeing accurate and efficient therapy for each patient’s particular ailment.
Global Reach
Our Thioridazine Tablets are exported to numerous nations, which is something Aetos Pharma is extremely proud of. Because of the company’s commitment to increasing access to high-quality mental health treatments, it has formed agreements with distributors and healthcare organizations across many continents, allowing patients all over the world to make use of this great product.
Supporting Mental Health:
Aetos Pharma is highly committed to promoting mental health awareness and de-stigmatizing mental health disorders. The company does more than only provide drugs. Aetos Pharma works to advance awareness, support, and acceptance of people with mental health disorders through partnerships with mental health groups.
Patient-centered and Accessible Approach:
Aetos Pharma optimizes the distribution process to ensure seamless accessibility to Thioridazine Tablets for patients worldwide by collaborating closely with distributors, medical specialists, and regulatory authorities in each nation.
Aetos Pharma Private Limited is a leading WHO-GMP EU-GMP Pharmaceuticals Manufacturer exports products to the following continents
Angola | Benin | Botswana | Burkina Faso | Burundi | Cameroon | Cape Verde | Central African Republic | Chad (Tchad) | Comoros | Republic of the Congo | Democratic Republic of the Congo | Côte d’Ivoire (Ivory Coast) | Djibouti | Equatorial Guinea | Egypt (Misr) | Eritrea | Ethiopia (Abyssinia) | Gabon | The Gambia | Ghana | Guinea | Guinea-Bissau | Kenya | Lesotho | Liberia | Libya | Madagascar | Malawi | Algeria | Mali | Mauritania | Mauritius | Morocco (Al Maghrib) | Mozambique | Namibia | Niger | Nigeria | Rwanda | São Tomé and Príncipe | Senegal | Seychelles | Sierra Leone | Somalia | South Africa | South Sudan | Sudan | Swaziland (Eswatini) | Tanzania | Togo | Tunisia | Uganda | Western Sahara | Zambia | Zimbabwe
Afghanistan | Armenia | Azerbaijan | Bahrain | Bangladesh | Bhutan | Brunei | Cambodia (Kampuchea) | Georgia | India | Indonesia | Iran | Iraq | Japan | Jordan (Al Urdun) | Kazakhstan | Kuwait | Kyrgyzstan | Laos | Lebanon (Lubnan) | Malaysia | Maldives | Mongolia | Myanmar (Burma) | Nepal | North Korea | Oman | Philippines | Qatar | Russia | Saudi Arabia | Singapore | South Korea | Sri Lanka | Syria | Tajikistan | Thailand | Turkey | Turkmenistan| Taiwan | United Arab Emirates | Uzbekistan | Vietnam | Yemen
Albania | Andorra | Austria | Belarus | Belgium | Bosnia and Herzegovina | Bulgaria | Croatia | Cyprus | Czech Republic | Denmark | Estonia | Finland | Georgia | Germany | Greece | Hungary | Iceland | Republic of Ireland | Italy | Kosovo | Latvia | Liechtenstein | Lithuania | Luxembourg | North Macedonia | Malta | Moldova | Monaco | Montenegro | Netherlands | Norway | Poland | Portugal | Romania | San Marino | Serbia | Slovakia | Slovenia | France | Spain | Sweden | Switzerland | Ukraine | United Kingdom
Canada | United States of America | Navassa Island | Puerto Rico | US Virgin Islands | Guam | American Samoa
Brazil | Argentina | Bolivia | Chile | Colombia | Ecuador | Falkland Islands | French Guiana | Guyana | Paraguay | Peru | South Georgia and the South Sandwich Islands | Suriname | Uruguay | Venezuela | Belize | Costa Rica | El Salvador | Guatemala | Honduras | Nicaragua | Panama | Dominican Republic | Mexico | Haiti | Antigua and Barbuda | Bahamas | Barbados | Cuba | Dominica | Grenada | Jamaica | Saint Lucia | Saint Kitts and Nevis | Saint Vincent and the Grenadines | Trinidad and Tobago
Australia | Fiji | New Zealand | Federated States of Micronesia | Kiribati | Marshall Islands | Nauru | Palau | Papua New Guinea | Samoa | Solomon Islands | Tonga | Tuvalu | Vanuatu